{"id":"W4386520704","doi":"10.1016/j.cardfail.2023.08.020","title":"The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF","year":2023,"lang":"en","type":"article","venue":"Journal of Cardiac Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Relypsa; Respicardia; Institut de Recherches Servier; American Regent; National Institutes of Health; Institut Servier; Vifor Pharma; Deutsche Forschungsgemeinschaft; Pfizer; Moderna; Impulse Dynamics; ReCor Medical; Sarepta Therapeutics; Cytokinetics; Ionis Pharmaceuticals; Canadian Cardiovascular Society; Sanofi Pasteur; Kowa Company; Celladon Corporation; Verily Life Sciences; Abbott Vascular; Heart Failure Society of America; Sanofi; LivaNova; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim; Amgen; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences","keywords":"Medicine; Hazard ratio; Heart failure; Internal medicine; Confidence interval; Placebo; Randomization; Ejection fraction; Randomized controlled trial; Cardiology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008122639,0.0002202891,0.001270821,0.0006961405,0.00004780293,0.00002008805,0.000133359,0.00006230907,0.00001581434],"category_scores_gemma":[0.0001140122,0.0001082442,0.0004120682,0.001627273,0.00009335249,0.0001799472,0.0000336468,0.0001951227,0.000003696071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001115807,"about_ca_system_score_gemma":0.00008900054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001133075,"about_ca_topic_score_gemma":0.0001114383,"domain_scores_codex":[0.9975808,0.000301129,0.0006212033,0.000173865,0.001060434,0.0002625611],"domain_scores_gemma":[0.9981565,0.0002299577,0.0006189331,0.0003933258,0.0004424083,0.0001588693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003768113,0.0002317903,0.9864311,0.00008944446,0.005842133,0.00005441628,0.0007447487,0.0004524769,0.00009971156,0.00001038396,0.001008071,0.00126764],"study_design_scores_gemma":[0.007766376,0.01063654,0.9685969,0.0002876679,0.006704032,0.000003437886,0.0008844631,0.0001238449,0.001237345,0.000004384103,0.003626421,0.0001285542],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981141,0.00008682333,0.000006193097,0.0006948716,0.00009989394,0.0006732835,0.00001198067,0.00001263536,0.0003002022],"genre_scores_gemma":[0.9994202,0.00005479025,0.0002912911,0.00001231404,0.00003169931,0.00001845994,0.00004488378,0.00002321348,0.0001031037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01783414,"threshold_uncertainty_score":0.4414069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005638720288965467,"score_gpt":0.2585413967872454,"score_spread":0.25290267649828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}